Ultimovacs ASA: Mandatory notification of trades by primary insider

Oslo, 9 March 2024: Langøya Invest AS, a closely related party of Ketil Fjerdingen, a board member and primary insider in Ultimovacs ASA, sold on 8 March 2024, 400,000 shares in the company at an average price of NOK 7.8984 per share. Following these transactions, Langøya Invest AS and closely related parties hold 400,000 shares in Ultimovacs ASA.

This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.

Attachment

• 20240309 - Ultimovacs Notification of trade - PDMR form

You May Also Be Interested In

• Vita Pop Officially Launches in the U.S. with Kansas City Celebration at Rock Island Bridge
• Gold Coast Health Plan Awards More than $2 Million in Grants to Providers and Community Organizations to Help Medi-Cal Members Navigate Changes
• Illinois American Water Emphasizes the Importance of Source Water Protection During Annual Recognition Week